Ysios et al. raise €15.5m series-B for CorWave

The deal saw existing shareholders Sofinnova Partners, BPI France and Seventure Partners participating in the round, alongside new investor Novo Seeds, which led the round. As part of the deal, Ysios general partner Josep Lluis Sanfeliu and Novo Seeds investment director Emmanuelle Coutanceau will join the company's board of directors.

According to a statement, the funding round will allow the company to conduct its first clinical study.

Previous funding
In 2011, the company was incorporated by medtech incubator MD Start and more recently raised a €3.3m series-A round in 2013.

Company
Founded in 2011 and headquartered in Paris, CorWave develops mechanical circulatory devices, including medical pumps focusing on mimicking the native heart flow pattern and correcting main heart failure symptoms.

The pre-revenue business employs a staff of 20.

People
Ysios Capital – Josep Lluis Sanfeliu (general partner).
Novo Seeds – Emmanuelle Coutanceau (investment director).
Sofinnova Partners – Antoine Papiernik (managing partner).
CorWave – Gérard Hascoët (chair); Louis de Lillers (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Healthcare
• France
• Venture
• Ysios Capital
• Sofinnova Partners
• BPI France
• Seventure (SPEF)